Marta Feldmesser

Title: Marta Feldmesser: Innovator in Diagnostic Technology

Introduction

Marta Feldmesser is a prominent inventor based in New York, NY (US), known for her significant contributions to the field of diagnostic technology. With a total of two patents to her name, she has focused her research on improving the diagnosis of microbial infections, particularly fungal infections that pose serious health risks.

Latest Patents

Feldmesser's latest patents include a lateral flow device designed for diagnosing microbial infections. Fungal infections, such as aspergillosis, are notoriously difficult to diagnose and can lead to high mortality rates. Traditional methods of culturing the organism are challenging, and obtaining samples through procedures like lung biopsies can result in additional morbidity. To address this issue, Feldmesser's invention seeks to identify biomarkers that indicate early infection. One such biomarker is galactomannan (GM), a polysaccharide found in the cell walls of hyphal cells, which is secreted during the organism's growth and excreted in urine. Her lateral flow assay utilizes monoclonal antibodies that specifically recognize GM residues in urine samples, providing a point-of-care detection device that allows for frequent screening and early diagnosis in patients at high risk for infection.

Career Highlights

Throughout her career, Feldmesser has worked with esteemed institutions, including The Johns Hopkins University and Yeshiva University. Her work has significantly advanced the understanding and diagnosis of fungal infections, contributing to better patient outcomes.

Collaborations

Some of her notable collaborators include Kieren Marr and Janet F. Staab, who have worked alongside her in various research initiatives.

Conclusion

Marta Feldmesser's innovative work in diagnostic technology exemplifies her commitment to improving healthcare through early detection of infections. Her contributions are vital in the ongoing battle against fungal infections, showcasing the importance of innovation in medical diagnostics.